(NASDAQ: QURE) Uniqure Nv's forecast annual revenue growth rate of 123.29% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 101.28%, and it is also forecast to beat the US market's average forecast revenue growth rate of 25.62%.
Uniqure Nv's revenue in 2025 is $15,751,000.On average, 15 Wall Street analysts forecast QURE's revenue for 2025 to be $1,086,740,353, with the lowest QURE revenue forecast at $856,448,075, and the highest QURE revenue forecast at $1,759,428,021. On average, 15 Wall Street analysts forecast QURE's revenue for 2026 to be $2,804,308,377, with the lowest QURE revenue forecast at $647,085,795, and the highest QURE revenue forecast at $9,098,320,298.
In 2027, QURE is forecast to generate $12,668,255,504 in revenue, with the lowest revenue forecast at $4,395,922,658 and the highest revenue forecast at $23,502,021,533.